Christopher Dereppe and Bruno André participated to the last “TOR de France” meeting organized at Nice on 5-6 October. This international meeting gathers every two years, in a nice place in France, scientists studying the “Target Of Rapamycin” (TOR) kinase complex involved in control of cell growth and associated with several diseases including cancers. The meeting was of high interest and offered an opportunity to meet again many colleagues interested in TOR.
Leave a Reply